Join us on Whatsapp: +91 7977614821 OR Click here to directly join now!

Wednesday, June 21, 2017

CDSL IPO Subscription Status Day 3: Wednesday, 21st June 2017, 3.00pm QIB : 115.66x,
HNI : 289.21x
Retail : 18.77x
Employee : 1.33x,
Overall : 101.51x

Monday, June 12, 2017

Issue opens on: Jun 14, 2017
Issue closes on: Jun 16, 2017
Issue size: Rs.450 Crs vide Fresh Issue and Rs.326 Crs through Offer for Sale
Price Band: Rs.250 to Rs.257 per equity shares
Bid Lot: 55 Equity Shares and in multiples thereof

Log on to for more

Issue opens on: Jun 16, 2017
Issue closes on: Jun 20, 2017
Issue size: 28,875,000 Equity Shares of Rs.1 each
Price Band: Rs.600 to Rs.603 per equity shares
Bid Lot: 24 Equity Shares and in multiples thereof

Issue opens on: Jun 19, 2017
Issue closes on: Jun 21, 2017
Issue size: 35,167,208 Equity Shares of Rs 10
Price Band: Rs.145 to Rs.149 per equity shares
Bid Lot: 100 Equity Shares and in multiples thereof

Central Depository Services (India) Limited (CDSL), a subsidiary of BSE Limited operates as a securities depository in India. They offers various services, such as account opening, dematerialization, processing delivery and receipt instructions, account statement, re-materialization, pledging, nomination, transmission of securities, change in address, bank account details and SMS services for depository participants.

CDSL also offers facilities to issuers to credit securities to a shareholder's or applicant's demat accounts; KYC services in respect of investors in capital markets to capital market intermediaries; and facilities to allow holding of insurance policies in electronic form to the holders of these insurance policies of various insurance companies.

In addition, they provides other online services, such as e-voting, e-locker, national academy depository, electronic access to security information, electronic access to security information and execution of secured transaction, drafting and preparation of wills for succession, and mobile application and transactions using secured texting. It serves investors through intermediaries, such as depository participants, issuer companies, registrar and transfer agents, beneficial owners, and clearing members.

Thursday, June 8, 2017

Eris Lifesciences Limited is planning to hit the streets with an IPO which would be open for subscription between June 16, 2017 and June 20, 2017

Eris Lifescience Ltd is Ahmedabad, Gujrat based pharmaceutical company engaged in research, development, manufacturing and selling of select therapeutic areas within the chronic and acute categories of the Indian Pharmaceutical Market.

Eris product portfolio is primarily focused on therapeutic areas which require the intervention of super specialist and specialist doctors such as Diabetologists, Endocrinologists Cardiologists, and Gastroenterologists.

Eris products in the chronic category cater primarily to the therapeutic areas including cardiovascular, anti-diabetics and neurology, chronic respiratory and chronic pain (analgesics)

The objects of the Offer are:
1. To achieve the benefits of listing the Equity Shares on the Stock Exchanges and 
2. For the sale of up to 28,875,000 Equity Shares by the Selling Shareholders.

The Offer comprises the Fresh Issue and the Offer for Sale.

1. Offer for Sale - The company will not receive any proceeds from the Offer for Sale.

2. Fresh Issue - Company proposes to utilize the Net Proceeds towards funding the following objects:

A. Capital expenditure towards payment of salaries and wages of research and development team;
B. Working capital requirement; and
C. General corporate purposes.

12 Fundamentally strong stocks near their 52W low

Infosys Ltd  - IT Services & Consulting

Sun Pharmaceutical Industries Ltd - Pharmaceuticals

Tech Mahindra Ltd - IT Services & Consulting

Aurobindo Pharma Ltd - Pharmaceuticals

Torrent Pharmaceuticals Ltd - Pharmaceuticals

Glenmark Pharmaceuticals Ltd - Pharmaceuticals

Divi's Laboratories Ltd - Labs & Life Sciences Services

Amara Raja Batteries Ltd - Batteries

Ajanta Pharma Ltd - Pharmaceuticals

Alembic Pharmaceuticals Ltd - Pharmaceuticals

Dr. Lal PathLabs Ltd - Hospitals & Diagnostic Centres

Eclerx Services Ltd - Outsourced services

Study the fundamentals and trends of the companies in detail before you start investing.

Monday, June 5, 2017

Issue Opens on : 19 June 2017
Issue Closes on: 21 June 2017
Price Band : Rs 113 – Rs 115 per equity share
Market Lot : 130 equity shares
Minimum Investment : Rs 14,950
Listing on: NSE, BSE

Friday, June 2, 2017

Following IPOs are expected to hit the streets in June 2017. Tentative Dates and details given below

1) Tejas Network IPO
     IPO Dates - June 12 - June 14, 2017
     Issue Size - 800 cr
     Retail portion - 10%

2) Eris Lifescience IPO
    IPO Dates - June 13 to June 15, 2017
    Issue Size - 1800 cr
    Retail portion - 10%

    IPO Dates - June 19 to June 21, 2017
    Issue Size - 400 cr
    Retail portion - 35%

4) A U Financials IPO
    Dates - June 22 to June 24, 2017

    Dates - 3rd or 4th week of June 2017

6) Pratap Snacks IPO
    Dates - 3rd or 4th week of June 2017

Thursday, June 1, 2017

CDSL IPO – Issue Information: (Tentative)

Issue Opens on: 19 June 2017
Issue Closes on: 21 June 2017
Issue Type: Book Built Issue IPO
Issue Size: 3,51,67,208 Equity Shares
Face Value: Rs 10 per Equity Share
Issue Price: Rs.140 – Rs.142 per Equity Share
Market Lot: 105 shares
Listing At: NSE, BSE

Category-wise Break up:.
Anchor – 1,03,40,162 Shares = 146.83Crs
QIB – 68,93,442 Shares = 97.89Crs
NII – 51,70,081 Shares = 73.42Crs
RII – 1,20,63,523 Shares = 171.30Crs (Lot size: 105 = 114,891 Forms)
Employees – 7,00,000 Shares = 9.94Crs

Total Issue – 3,51,67,208 Equity Shares = 499.37Crs.

Subscription required for 1X
RII = 114,891 Forms
NII = 73.42 Crores

Tuesday, May 30, 2017

30 MAY, 2017


2. BEL
11. IRB
13. M&M
15. MFSL
16. NHPC
17. PVR
20. SAIL

Indian IPO Blog Feed Subscribers

Enter your email address:

Delivered by FeedBurner

- Disclaimer / Terms of Use
- Privacy Policy

Subscribe via email

Enter your email address:

Delivered by FeedBurner

By visiting or accessing this Blog and any/all of its subdomains, you solemnly declare that you have read, understood and agree to - Disclaimer / Terms of Service
View our - Privacy Policy

Trending IPO News

Blog Archive

Feed Subscribers